Recursion uses AI to decode disease biology at scale. The company generates massive biological datasets by running millions of lab experiments, then uses machine learning to identify potential drug candidates. Recursion is one of the most computationally intensive biotechs, with a proprietary OS (Operating System) for biology.
IPO details
IPO date
Thu Apr 15
IPO price
—
First-day close
—
IPO valuation
$2.5B
Market-data summary
Current price
—
Market cap
—
Day range
—
52-week range
—
Data last checked Sat Oct 03. Optional market data is not yet available where shown as —.